Cargando…
Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study
Breast cancer risk is increased with current Menopausal Hormone Therapy (MHT) use, with higher risks reported for ER+ (Estrogen Receptor positive), and ER+/PR+ (Estrogen and Progesterone Receptor positive) breast cancers than those of ER- and ER-/PR- status, respectively. There is limited evidence t...
Autores principales: | Salagame, Usha, Banks, Emily, O’Connell, Dianne L., Egger, Sam, Canfell, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221262/ https://www.ncbi.nlm.nih.gov/pubmed/30403669 http://dx.doi.org/10.1371/journal.pone.0205034 |
Ejemplares similares
-
Accurate categorisation of menopausal status for research studies: a step-by-step guide and detailed algorithm considering age, self-reported menopause and factors potentially masking the occurrence of menopause
por: Yap, Sarsha, et al.
Publicado: (2022) -
Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations
por: Velentzis, Louiza S., et al.
Publicado: (2017) -
Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study
por: Velentzis, Louiza S., et al.
Publicado: (2016) -
Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data
por: Smith, David P., et al.
Publicado: (2018) -
Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women: Case–Control Study
por: Urban, Margaret, et al.
Publicado: (2012)